Navigating Drug Pricing Reforms

This chapter explores the complexities of drug pricing negotiations within the U.S. healthcare system, focusing on recent administration announcements and their contrast with the Inflation Reduction Act. It highlights the challenges faced by seniors and individuals with disabilities in accessing affordable medications, emphasizing the need for effective negotiation within Medicare. Additionally, the discussion examines the implications of previous administrations' approaches and the importance of statutory law in enabling meaningful reforms.